EAPC congress

Important information about the 2025 EAPC Congress abstract submission process 

You may be an experienced EAPC abstract submitter or this might be your first time submitting your work to EAPC congress. Either way, there is some essential information that you need to know about the abstract submission process for EAPC2025.   Everything you need to know about the abstract submission process is on our congress website: […]

Important information about the 2025 EAPC Congress abstract submission process  Read More »

Announcing the 2024 EAPC Researcher Award Winners!

The EAPC Researcher Awards have been established to acknowledge those individuals who have made significant contributions to research and clinical practice in palliative care. There are three award categories: The recipients of these prestigious awards are selected by the scientific committee of the congress. The awardees represent the pinnacle of excellence within the palliative care

Announcing the 2024 EAPC Researcher Award Winners! Read More »

EAPC Researcher Awards 2024: Application process now open!

The EAPC Researcher Awards are designed to recognise the work of researchers and clinicians in the field of palliative care who have recently made, or are currently making, an outstanding contribution to research and clinical practice, public advocacy, policy, or education. The aim is to highlight the individual’s career development and their actual and potential

EAPC Researcher Awards 2024: Application process now open! Read More »

Ready for the Future: Your opportunity to shape the content presented at EAPC 2025 in Helsinki!

EAPC has launched the call for proposals for themed sessions for the 2025 World Congress in Helsinki (29-31 May, 2025). All the information about the call can be found at this page In the past we would have referred to these sessions as ‘parallel sessions’. For 2025 we are seeking proposals for sessions that can

Ready for the Future: Your opportunity to shape the content presented at EAPC 2025 in Helsinki! Read More »